UNSPSC 85612924: Supplement accessory pancreatic duct with autologous tissue substitute, open approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement accessory pancreatic duct with autologous tissue substitute, open approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0FUF07Z

UNSPSC 85612924 Supplement accessory pancreatic duct with autologous tissue substitute, open approach is a Commodity code that describes a highly specialized surgical procedure for pancreatic duct repair using tissue grafting. The recent state and local contract opportunities tagged under this code show no alignment with the code's clinical scope; instead, they capture independent medical evaluation services, occupational health surveillance, pharmacy benefit management, temporary health professional staffing, surgical procedure carve-out networks, and emergency youth detention healthcare—none of which involve pancreatic duct surgery or autologous tissue substitution. The code shows little relevant recent activity under its nominal scope.

State and local procurement offices appear to be using this code as a catchall for healthcare management and staffing services rather than for the specific surgical procedure it names. The City of Phoenix Retirement Office, the Washington State Department of Transportation, Harris County Juvenile Probation Department, Collier County Board of County Commissioners, the County of Santa Clara Health System, and the City of Long Beach have posted solicitations under this code, but all are seeking administrative health services, occupational medicine programs, or clinical staffing arrangements. No solicitation explicitly requests pancreatic duct surgical services or related implant materials. Until state and local procurement offices post opportunities that actually match the surgical procedure described in the code's name, this Commodity code does not represent a viable market for surgical device or tissue graft vendors.